Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes
Although most patients with differentiated thyroid cancer (DTC) and biochemical incomplete response (BIR) follow a good clinical outcome, progression to structural disease may occur in 8–17% of patients. We aimed to identify factors that could predict the long-term outcomes of BIR patients. To this...
Guardado en:
Autores principales: | Miriam Steinschneider, Jacob Pitaro, Shlomit Koren, Yuval Mizrakli, Carlos Benbassat, Limor Muallem Kalmovich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c25d8de3d649403d97f0a7088c5623da |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tiroglobulina y sus limitaciones en el seguimiento del carcinoma diferenciado del tiroides: Report of two cases
por: Velasco L,Soledad, et al.
Publicado: (2007) -
Importancia de la tiroglobulina sérica preablativa en la predicción de sobrevida libre de enfermedad en cáncer diferenciado de tiroides
por: Díaz,René E, et al.
Publicado: (2013) -
Identification of key genes and miRNAs markers of papillary thyroid cancer
por: Qiu,Jie, et al.
Publicado: (2018) -
Unusual locations for differentiated thyroid cancer nodal metastasis
por: Rohit Ranganath, et al.
Publicado: (2020) -
Papillary thyroid carcinoma in a 5-year old child, mimicking lymphoma in presentation
por: Tariq N Aladily, et al.
Publicado: (2021)